Clinical Trial Update: Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating sildenafil for moderate congestive heart failure was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of New Mexico | Conditions: Heart Failure | Phase 4 | Status: WITHDRAWN